Page last updated: 2024-08-23

tetradecanoylphorbol acetate and 1-(1-glycero)dodeca-1,3,5,7,9-pentaene

tetradecanoylphorbol acetate has been researched along with 1-(1-glycero)dodeca-1,3,5,7,9-pentaene in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Devor, DE; Henneman, JR; Keefer, LK; Logsdon, DL; Rice, JM; Streeter, AJ; Ward, JM1
Hoshina, S; Morotomi, M; Ueffing, M; Weinstein, IB1
Farrow, S; Holloway, KA; Howells, L; Kaptein, A; Manson, MM; Munks, RJ; Plummer, SM1

Other Studies

3 other study(ies) available for tetradecanoylphorbol acetate and 1-(1-glycero)dodeca-1,3,5,7,9-pentaene

ArticleYear
Carcinogenicity study of fecapentaene-12 diacetate on skin painting in SENCAR mice.
    Cancer letters, 1991, Volume: 56, Issue:1

    Topics: Adult; Animals; Drug Combinations; Female; Humans; Mice; Mutagens; Papilloma; Polyenes; Skin Neoplasms; Tetradecanoylphorbol Acetate; Vitamin E

1991
Effects of a fecapentaene on protein kinase C.
    Biochemical and biophysical research communications, 1991, Apr-15, Volume: 176, Issue:1

    Topics: Animals; Brain; Calcium; Enzyme Activation; Kinetics; Mutagens; Phosphatidylserines; Polyenes; Protein Kinase C; Rats; Tetradecanoylphorbol Acetate

1991
Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-kappaB activation via the NIK/IKK signalling complex.
    Oncogene, 1999, Oct-28, Volume: 18, Issue:44

    Topics: Antineoplastic Agents; Caffeic Acids; Colonic Neoplasms; Curcumin; Cyclooxygenase 2; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; I-kappa B Kinase; I-kappa B Proteins; Isoenzymes; Membrane Proteins; NF-kappa B; NF-kappaB-Inducing Kinase; Phenylethyl Alcohol; Polyenes; Prostaglandin-Endoperoxide Synthases; Protein Serine-Threonine Kinases; Signal Transduction; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha

1999